by European College of Neuropsychopharmacology Credit: Pixabay/CC0 Public Domain Post-COVID trauma and the war in Ukraine means that millions of people are suffering or are at an increased risk of developing an “epidemic” of post-traumatic stress (PTSD). Now a new review suggests that combining established psychotherapy methods with newer pharmaceuticals may offer the best therapeutic approach...
Paul Tullis Illustration by Gizem Vural PDF version On a sunny day in London in 2015, Kirk Rutter rode the Tube to Hammersmith Hospital in hopes of finally putting an end to his depression. Rutter had lived with the condition off and on for years, but the burden had grown since the death of his...
MDMA (Methylenedioxymethamphetamine), commonly referred to as ecstasy, was manufactured as a potential pharmaceutical early last century. It had some limited use in the 1970s as a therapeutic aid in trauma treatment and in relationship counselling, and more recent studies using MDMA for trauma have shown some promise. MDMA itself isn’t a dangerous drug. But adulterants...
Ecstasy, or MDMA, has received ‘breakthrough status’ by the FDA for PTSD trials This means there is substantial evidence the ‘medication’ could benefit sufferers MDMA is thought to dampen down PTSD triggers, allowing them to be overcome Past studies show 61 out of 107 patients do not have symptoms one year later Assuming sufficient funding, the...
